Loading...

Harvard Bioscience, Inc.

HBIO•NASDAQ
Healthcare
Medical - Instruments & Supplies
$6.72
$-0.06(-0.88%)
U.S. Market is Open • 10:19

Harvard Bioscience, Inc. (HBIO) Stock Overview

Explore Harvard Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap30.7M
P/E Ratio-0.54
EPS (TTM)$-12.80
ROE-3.89%
Fundamental Analysis

AI Price Forecasts

1 Month$4.61
3 Months$1.05
1 Year Target$0.00

HBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harvard Bioscience, Inc. (HBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.54 and a market capitalization of 30.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.18%
5-Day Change
16.67%
1-Month Change
33.72%
3-Month Change
15.88%
6-Month Change
68.14%
Year-to-Date (YTD) Change
2.54%
1-Year Change
75.90%
3-Year Change
-86.00%
5-Year Change
-90.20%
All-Time (Max) Change
-91.45%

Contact Information

https://www.harvardbioscience.com
508 893 8999
84 October Hill Road, Holliston, MA, 01746

Company Facts

330 Employees
IPO DateMar 19, 2001
CountryUS
Actively Trading

Frequently Asked Questions